CATHERINE SMITH: Open Payments
NPI 1730845454 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $408 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 2 | $187 |
| ABBVIE INC. | 8 | $158 |
| UCB, Inc. | 3 | $101 |
| Galderma Laboratories, L.P. | 1 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| GENZYME CORPORATION | 1 | $30 |
| Incyte Corporation | 1 | $29 |
| Amgen Inc. | 1 | $25 |
| Journey Medical Corporation | 1 | $22 |
Products named: Zoryve, Bimzelx, NEMLUVIO, RINVOQ, SKYRIZI, COSENTYX, ILUMYA, DUPIXENT.
Industry payments across NC — which companies pay providers there.
